The design of biodegradable ofloxacin-based core-shell microspheres: Influence of the formulation parameters on in vitro characterization
Authors:
- Ali Demir SezerASAli Demir Sezer
- Jülide AkbuğaJAJülide Akbuğa
- 16 June 2010
- journal article
- research article
- Published by Taylor & Francis in Pharmaceutical Development and Technology
- Vol. 17 (1) , 118-124
Abstract
Ofloxacin (OFL), second-generation fluoroquinolone, is a broad-spectrum antibiotic which is active against both Gram-positive and Gram-negative bacteria. However, OFL has a short biological half life (8–9 h) and poor stability in serum and needs frequently repeated doses during the treatment. The objective of this study was to fabricate the fucospheres and chitosan microspheres containing a poorly soluble drug, OFL, and to compare the formulation parameters influencing the in vitro properties of microparticles such as size, zeta potential, encapsulation efficiency and drug release characteristics. Particle size of fucospheres and chitosan microspheres has been found to be 0.61–1.48 µm and 1.05–2.08 µm, respectively. The zeta potentials have changed between 5.6 mV and 28.0 mV for fucospheres; 22.3 mV and 42.4 mV for chitosan microspheres. The fucospheres have had higher drug encapsulation efficiency than those of chitosan microspheres. The particle size, surface charge, encapsulation efficiency and in vitro drug release from both fucospheres and chitosan microspheres have been affected by type and concentration of the polymers used. The release mechanism from most of the microsphere formulations has been fitted to Higuchi kinetic model. It can be concluded that OFL-encapsulated fucospheres can be a potential delivery system for antibiotics.Keywords
This publication has 36 references indexed in Scilit:
- Ofloxacin targeting to lungs by way of microspheresInternational Journal of Pharmaceutics, 2009
- In vitro and in vivo evaluation of ofloxacin sustained release pelletsInternational Journal of Pharmaceutics, 2008
- In Vitro Evaluation of Enrofloxacin-Loaded MLV LiposomesDrug Delivery, 2007
- Investigation of chromatographic conditions for the separation of ofloxacin and its degradation productsJournal of Chromatography A, 2006
- Novel sustained release, swellable and bioadhesive gastroretentive drug delivery system for ofloxacinInternational Journal of Pharmaceutics, 2006
- Encapsulation of Enrofloxacin in Liposomes I: Preparation and In Vitro Characterization of LUVJournal of Liposome Research, 2004
- Sustained ophthalmic delivery of ofloxacin from a pH triggered in situ gelling systemJournal of Controlled Release, 2001
- Uptake and intracellular activity of ofloxacin isomers in human phagocytic and non-phagocytic cellsInternational Journal of Antimicrobial Agents, 2000
- Activities of ciprofloxacin, levofloxacin, ofloxacin and sparfloxacin against speciated coagulase-negative staphylococci sensitive and resistant to fluoroquinolonesInternational Journal of Antimicrobial Agents, 1997
- Determination of ofloxacin in human aqueous humour by high-performance liquid chromatography with fluorescence detectionJournal of Pharmaceutical and Biomedical Analysis, 1997